相关实验视频
Updated: May 26, 2026

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
在静脉和皮下注射后,阿尔帕卡的多克西环素的药理动力学
José Martínez1, Pedro Marín1, David A Egas2
1Department of Pharmacology, Campus de Espinardo, University of Murcia, 30100 Murcia, Spain.
Antibiotics (Basel, Switzerland)
|March 28, 2025
概括
这项研究研究了阿尔帕卡斯的多克西环林药理动力学. 静脉注射和皮下注射的多西环素显示出良好的分布,但通过皮下途径的生物可用性较低,这表明每24小时20毫克/公斤的潜在疗效.
科学领域:
- 兽医药理学 兽医药理学
- 抗微生物药物的药理动力学
- 卡梅利德医学 卡梅利德医学
背景情况:
- 西环素是兽医中广泛使用的抗生素.
- 有限的药理动力学数据存在于阿尔帕卡斯的多克西环林使用.
- 了解多西环素的药理动力学对于阿尔帕卡斯的有效治疗方案至关重要.
研究的目的:
- 为了描述阿尔帕卡斯中多克西环素的药理动力学.
- 在静脉注射 (IV) 和皮下 (SC) 给药后评估多西环素的药理动力学.
- 为了确定阿尔帕卡斯中多克西环林的最佳剂量方案.
主要方法:
- 一个随机交叉研究设计被用在六只阿尔帕卡.
- 西环素被静脉注射为5mg/kg,并被皮下注射为20mg/kg.
- 使用HPLC-UV测量了多西环林在血中的度,并在服用后96小时内测量,并通过非分隔方法进行分析.
主要成果:
- 静脉注射显示出良好的分布 (Vz = 0.90 L/kg).
- 皮下施用导致Cmax为1.40μg/mL在1.92小时,生物可用性低 (F=36.83%).
- 药理动力学/药理动力学 (PK/PD) 比率表明,在特定的最小抑制度 (MICs) 中,每24小时服用20 mg/kg的下剂量可能有潜在的疗效.
结论:
- 对于IV和SC路径,阿尔帕卡的多西环素药理学得到了阐明.
- 通过SC路线证明生物利用率较低,需要仔细考虑剂量.
- 这项研究表明,阿尔帕卡鱼的多克西环素可能具有有效的SC剂量方案,但需要进一步的研究.
相关概念视频
Routes of Drug Administration: Parenteral
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Dosage Interval and Administration Route: Determination Methods
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...

